Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hammerstrom

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Environmental Research|December 1, 1992
Temporal patterns in air pollution and hospital admissionsF W Lipfert, T Hammerstrom
Journal of Biopharmaceutical Statistics|July 1, 1997
Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysisY Tsong, T Hammerstrom, J J Chen
Journal of Biopharmaceutical Statistics|July 1, 1995
Dissolution test acceptance sampling plansY Tsong, T Hammerstrom, K Lin, et al.
JAPCA|June 1, 1989
Health risks of short-term SO2 exposure to exercising asthmaticsP C Freudenthal, H D Roth, T Hammerstrom, et al.
Journal of Clinical Epidemiology|January 1, 1996
Sedative-hypnotic drugs and the risk of hip fractureD K Wysowski, C Baum, W J Ferguson, et al.
Pharmacoepidemiology and Drug Safety|May 1, 1996
Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whitesD G Burkhart, N J Brown, M R Griffin, et al.
The New England Journal of Medicine|May 1, 1997
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosisS C FitzSimmons, G A Burkhart, D Borowitz, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Environmental Research|December 1, 1992
Temporal patterns in air pollution and hospital admissionsF W Lipfert, T Hammerstrom
Journal of Biopharmaceutical Statistics|July 1, 1997
Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysisY Tsong, T Hammerstrom, J J Chen
Journal of Biopharmaceutical Statistics|July 1, 1995
Dissolution test acceptance sampling plansY Tsong, T Hammerstrom, K Lin, et al.
JAPCA|June 1, 1989
Health risks of short-term SO2 exposure to exercising asthmaticsP C Freudenthal, H D Roth, T Hammerstrom, et al.
Journal of Clinical Epidemiology|January 1, 1996
Sedative-hypnotic drugs and the risk of hip fractureD K Wysowski, C Baum, W J Ferguson, et al.
Pharmacoepidemiology and Drug Safety|May 1, 1996
Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whitesD G Burkhart, N J Brown, M R Griffin, et al.
The New England Journal of Medicine|May 1, 1997
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosisS C FitzSimmons, G A Burkhart, D Borowitz, et al.
Pageof 1